Apimeds (APUS) Fundamental Analysis: Revenue, Earnings & Valuation

8.57 / 10

Outperform

Fundamentals rate Outperform (8.6/10). Strong interest coverage (15.6x) and revenue‑to‑market advantage, high asset‑to‑market and PB‑ROE scores. Inventory turnover is healthy. Concerns: 100% current liabilities ratio and zero long‑term debt to working capital, which may limit flexibility.

Analysis Checks(8/10)

Revenue-MV

Value-0.28

Score3/3

Weight36.04%

1M Return8.11%

Total operating revenue (YoY growth rate %)

Value78.03

Score2/3

Weight0.50%

1M Return0.13%

Inventory turnover ratio

Value47.95

Score2/3

Weight-4.11%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value100.00

Score1/3

Weight-5.75%

1M Return-1.69%

PB-ROE

Value1.38

Score2/3

Weight33.62%

1M Return7.29%

Long-term debt to working capital ratio (%)

Value0.00

Score0/3

Weight-15.66%

1M Return-4.75%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight-4.18%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value92.19

Score2/3

Weight0.20%

1M Return0.05%

Cost of sales ratio (%)

Value70.31

Score2/3

Weight-3.95%

1M Return-1.13%

Asset-MV

Value-0.49

Score3/3

Weight63.28%

1M Return11.61%

Is APUS fundamentally strong?

APUS scores 8.57/10 on fundamentals and holds a Discounted valuation at present. Backed by its -142.47% ROE, 0.00% net margin, -6.37 P/E ratio, 2.90 P/B ratio, and -75.86% earnings growth, these metrics solidify its Outperform investment rating.